CovidVax show full list
COVID-19 VACCINE:

VAAST Oral Vaccine platform

researcher:
Vaxart + Emergent BioSolutions + KindredBio
https://vaxart.com/
https://www.emergentbiosolutions.com/
https://kindredbio.com/
(USA)
vaccine type: Non-replicating viral vector
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)

PHASE 1

 

started September 24 2020

with 48 healthy volunteers aged 18-54

trial location: USA

» clinical trial details

Oct 13Vaxart announced that the first subject has been dosed with the vaccine in its Phase 1 clinical trial (by globenewswire.com)
Sep 14U.S. FDA gave clearance of IND application for Vaxart's vaccine which will start Phase 1 trials this month (by vaxart.com)
Apr 21Vaxart expects to start clinical trials for its vaccine in the second half of 2020 (by biospace.com)
Animal Testing updates (pre-clinical trials)
start date: April 2020
Sep 08Vaxart's oral vaccine induced potent systemic and mucosal immune responses in preclinical studies (by vaxart.com)
Apr 21Vaxart vaccine pre-clinical tests generated immune responses in all tested animals (by globenewswire.com)
early development updates
Mar 31Vaxart have produced 5 vaccine candidates for testing in its pre-clinical trials (by reuters.com)



partnerships:
May 20Vaxart has contracted with KindredBio to manufacture its lead vaccine candidate at a large scale (by immunofrontiers.com)
Mar 18Vaxart partners with Emergent to develop an oral recombinant vaccine candidate (by emergentbiosolutions.com)



contact | about | ©2020 CovidVax.org project